Summary
A rat cell line-nominated CC-62 derived from a combined hepatocellular and cholangiocellular carcinoma obtained by administration of 2-acetylaminofluorene to male Wistar rats, has been established. Using light and electron microscopy it was determined that morphologically the tumor consisted of a mixed population of hepatocytes and cholangiolar neoplastic cells, intermingled with small, undifferentiated oval-like cells. The CC-62 line has been maintained through 90 passages in culture adopting a paving stone arrangement. Doubling time at the 12th passage was 23 h. Immunostaining with a panel of antisera was performed to identify the cytological profiles of the cell line. There was no k-ras or p53 expression by immunohistochemistry, and molecular biology failed to detect mutations. Molecular analysis by reverse transcriptase-polymerase chain reaction revealed transcripts for c-met but no expression of HGF messenger ribonucleic acid. Three cell lines cloned from CC-62 showed the same immunohistochemical and molecular pattern as the parental line. Cytogenetic analysis revealed a chromosome number ranging from 74 to 82 with a modal number of 79 but no clonal structural abnormalities were found. Deoxyribonucleic acid ploidy analysis showed an aneuploid peak. CC-62 caused tumors 1 mo after subcutaneous transplantation into nude mice, with morphological patterns of mucosecretory solid and spindle-shaped carcinoma. This cell line is the first established from a primary rat combined hepatocellular and cholangiocellular neoplasm. The resulting cells expressed biological and morphological markers of hepatocytes and cholangiolar cells. Therefore this cell line may contribute to a better understanding of the histogenesis of liver cancer.
Similar content being viewed by others
References
Alison, M. Liver stem cell: a two compartment system. Curr. Opin. Cell Biol. 10:710–715; 1998.
Allen, R. A.; Lisa, J. R. Combined liver cell and bile duct carcinoma. Am. J. Pathol. 25:647–655; 1949.
Bisgaard, H. C.; Parmelee D. C.; Dunsford, H. A., et al. Keratin 14 protein in cultured nonparenchymal rat hepatic epithelial cells: characterization of keratin 14 and keratin 19 as antigens for the commonly used mouse monoclonal antibody OV-6. Mol. Carcinog. 7:60–66; 1993.
Comoglio, P. M. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells. EXS 65:131–165; 1994.
Cooper, C. S.; Park, M.; Blair, D. G., et al. Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature 311:29–33; 1994.
Crosby, H. A.; Hubscher, S. G.; Joplin, R. E., et al. Immunolocalization of OV6, a putative progenitor cell marker in human fetal and diseased pediatric liver. Hepatology 28:980–985; 1998).
Dabeva, M. D.; Shafritz, D. A. Activation, proliferation, and differentiation of progenitor cells into hepatocytes in the d-galactosamine model of liver regeneration. Am. J. Pathol. 144:849–854; 1993.
Di Renzo, M. F.; Narsimhan, R. P.; Olivero, M., et al. Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene 6:1997–2003; 1991.
Gherardi, E.; Gray, J.; Stoker, M., et al. Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interaction and movement. Proc. Natl. Acad. Sci. USA 88:415–419; 1991.
Imai, Y.; Oda, H.; Arai, M., et al. Mutational analysis of the p53 and k-ras genes and allelotype study of the Rb-1 gene for investigating the pathogenesis of combined hepatocellular-cholangiocellular carcinomas. Jpn. J. Cancer Res. 87:1056–1062; 1996.
Kitagawa, T. Histochemical analysis of hyperplastic lesions and hepatomas of the liver of rats fed 2 fluorenyl acetamide. Gann 62:207–216; 1971.
Lai, G.-H.; Sirica, A.-E. Establishment of a novel rat cholangiocarcinoma cell culture model. Carcinogenesis 20:2335–2339; 1999.
Lee, J.-H.; Rim, H.-J.; Sell, S. Heterogeneity of the “oval cells” response in the hamster liver during cholangiocarcinogenesis following Clonorchis Sinensis injection and dimethylnitrosamine treatment. J. Hepathol. 26:1313–1323; 1997.
Leong, A. S.-Y.; Sormunen, R. T.; Tsui, W. M. S.; Liew, C. T. Hep Par 1 and selected antibodies in the immunohistological distinction of hepato-cellular carcinoma from cholangiocarcinoma, combined tumours and metastatic carcinoma. Histopathology 33:318–324; 1998.
Levan, G. Nomenclature for G-bands in rat chromosomes, Hereditas 77:37–51; 1974.
Lin, Y.-Z.; Brunt, E. M.; Bouling, W., et al. Ras-transduced diethylnitrosamine-treated hepatocytes develop into cancers of mixed phenotype in vivo. Cancer Res. 55:5242–5250; 1995.
Masson, S.; Scotte, M.; François, A., et al. Changes in growth factor and cytokine mRNA levels after hepatectomy in rat with CC4-induced cirrhosis. Am. J. Physiol. 277 (Gastrointest. Liver Physiol. 40):G838-G846; 1999.
Michalopoulos, G. K.; DeFrances, M. C. Liver regeneration. Science 176:60–66; 1997.
Murakami, T.; Yano, H.; Maruiwa, M., et al. Establishment and characterization of a human combined hepatocholangiocarcinoma cell line and its heterologous transplantation in nude mice. Hepatology 7:551–556; 1987.
Nickell-Brady, C.; Hahn, F. F.; Finch, G. L., et al. Analysis of K-ras, p53 and c-raf-1 mutations in beryllium-induced rat lung tumors. Carcinogenesis 15:257–262; 1994.
Novikoff, P. M.; Yam, A.; Oikawa, I. Blast-like cell compartment in carcinogen-induced proliferating bile ductules. Am. J. Pathol. 148:1473–1492; 1996.
Radaeva, E.; Ferreira-Gonzalez, A.; Sirica, A. E. Overexpression of c-neu and c-met during rat liver cholangiocarcinogenesis: a link between biliary intestinal metaplasia and mucin-producing cholangiocarcinoma. Hepatology 29:1453–1462; 1999.
Roskams, T.; De Vos, R.; Van Eyken, P., et al. Hepatic OV-6 expression in human liver disease and rat experiments: evidence for hepatic progenitor cells in man. J. Hepatol. 29:455–463; 1998.
Sambrok, J.; Fritsch, E. F.; Maniatis, T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
Sell, S. Electron microscopic identification of putative liver stem cells and intermediate hepatocytes following periportal necrosis induced in rats by allyl alcohol. Stem Cells 15:378–385; 1997.
Sell, S.; Dunsford, H. A. Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. Am. J. Pathol. 134:1347–1363; 1989.
Shimosato, H.; Kameya, T.; Nagai, K., et al. Transplantation of human tumors in nude mice. J. Natl. Cancer Inst. 56:1251–1260; 1976.
Ueki, T.; Fujimoto, J.; Suzuki, T., et al. Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma. Hepatology 25:862–866; 1997.
Yang, L.; Faris, R.; Hixson, D. C. Phenotypic heterogeneity within clonogenic ductal cell populations isolated from normal adult rat liver. Proc. Soc Exp. Biol. Med. 204:280–288; 1993.
Yavorkovsky, L.; Lai, E.; Ilic, Z.; Sell, S. Participation of small intraportal stem cells in the restitutive response of the liver to periportal necrosis induced by allyl alcohol. Hepatology 21:1702–1712; 1995.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gil-Benso, R., Martinez-Lorente, A., Pellin-Perez, A. et al. Characterization of a new rat cell line established from 2′AAF-induced combined hepatocellular cholangiocellular carcinoma. In Vitro Cell.Dev.Biol.-Animal 37, 17–25 (2001). https://doi.org/10.1290/1071-2690(2001)037<0017:COANRC>2.0.CO;2
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1290/1071-2690(2001)037<0017:COANRC>2.0.CO;2